Skip to main content
Caplight Logo









ViAqua Therapeutics

ViAqua Therapeutics

Private
HaifaHealthcare & Life Scienceshttps://www.viaqua-t.com/

Last Round

VC Round

Sep 5, 2023

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ViAqua Therapeutics is a biotechnology company that has developed an orally administered RNA-particle platform to improve disease resistance in aquaculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service

AI Layer

Non-AI

Keywords

aquacultureRNA-based therapeuticsdsRNAdouble-stranded RNAoral delivery platformaquaculture healthfish farmingshrimp farmingfeed additivesdisease preventionbiotechaquafeedfish healthshrimp healthbiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViAqua Therapeutics Comparables

Compare ViAqua Therapeutics with similar companies based on industry and business-model similarity.

ViAqua Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AQVac LLC
86%
Redux Bio
85%
FeedVax
85%

ViAqua Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 5, 2023
VC RoundJun 9, 2021
SeedJul 5, 2018
AcceleratorSep 1, 2016

Key People

Founding team and executive leadership

Shai Ufaz

Co-Founder And CEO

Founding Team

ViAqua Therapeutics Investors

Notable investors and investment history

ViAqua Therapeutics investors
InvestorRounds
TechnionAccelerator, VC Round, Seed
S2G InvestmentsVC Round
Rabo VenturesVC Round
Clay CapitalVC Round
The Trendlines GroupVC Round, Seed, Accelerator
Clay CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 185% MoM.

ViAqua Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ViAqua Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ViAqua Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHaifa
Employee Range11
Year Founded2014
Last FundingSep 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?